Investments & digital assets › F8949.A.M12
F8949.A.M12 · federal · F8949 line A.M12
Meadowlark Biotech (acquired 2024-12-02, sold 2025-08-14; proceeds 2,460.00, basis 4,100.00)
-1,640
engine v3
not yet verified
How this number was built
R-8949-LOT One line per sale: proceeds minus basis plus adjustment. Broker basis is used as reported unless a supplemental statement for the same lot is matched.
Sources (6) — where the inputs came from
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 7 · field M12_description · “Lot M12 description”
read as “Meadowlark Biotech” → Meadowlark Biotech
99%
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 7 · field M12_acquired · “Lot M12 date acquired”
read as “12/02/2024” → 2024-12-02
99%
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 7 · field M12_sold · “Lot M12 date sold”
read as “08/14/2025” → 2025-08-14
99%
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 7 · field M12_proceeds · “Lot M12 proceeds”
read as “2,460.00” → 2,460
99%
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 7 · field M12_basis · “Lot M12 cost basis”
read as “4,100.00” → 4,100
99%
Meridian Brokerage 2025 consolidated Form 1099 - CORRECTED (joint)
D31 · page 7 · field M12_wash · “Lot M12 wash sale loss disallowed”
read as “0.00” → 0
99%
Flows into
History — nothing is overwritten
v1 · 2026-03-04: -1,640v2 · 2026-03-19: -1,640v3 · 2026-06-23: -1,640
Adjust this number
Evidence & discussion
Record how you verified it